# Freenome, Inc. (FRNM)

> Source: Nexqual · https://nexqual.com/FRNM · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Freenome, Inc. (FRNM), nexqual.com/FRNM" · informational, not investment advice.

**Price:** USD 12.29 (+0.78% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 12.19 · day 11.7–12.64 · 52w 9.95–17.5 · market cap $1.32B · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (5 analysts), mean target USD 18 (range 17–21).
- Total return with dividends: 1Y +15.5% vs S&P 500 +18.1%; 5Y +22.0% vs S&P 500 +85.1%.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2025 | TTM |
|---|---|---|
| Operating income | -$3.0M | -$4.3M |
| Net income | $837K | -$763K |
| Cash + short-term investments | $865K | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
Earnings yield -0.06%

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 5 analysts; mean target USD 18 (low 17, high 21).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-20 | Guggenheim | Initiated | Buy | $21 |
| 2026-08-18 | TD Cowen | Initiated | Buy | $17 |
| 2026-08-17 | Jefferies | Initiated | Buy | $17 |
| 2026-08-17 | BTIG | Initiated | Buy | $17 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-06-10) |
|---|---|---|
| Total return | +15.5% | +22.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +15.5% | +8.8% |
| Volatility (annualized) | 45.3% | 30.6% |
| Max drawdown | -29.6% (Jan 2026→Jul 2026) | -28.2% (Sep 2026→Oct 2026) |

## Peers (Diagnostics & Research)
OPK (Opko Health, Inc.) USD 1.61 +21.97% · CSTL (Castle Biosciences, Inc.) USD 33.8 +2.80% · PSNL (Personalis, Inc.) USD 15.93 +0.50% · WGS (GeneDx Holdings Corp.) USD 70.22 +8.10% · NEO (NeoGenomics, Inc.) USD 17.25 +3.54% · FLGT (Fulgent Genetics, Inc.) USD 21.34 +1.33%

## More
Full page: https://nexqual.com/FRNM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt